Immunogenicity 15701
Sample ID
3713
Response
Positive
Tumor Type
Melanoma
Gene Symbol
AFMID
Transcript ID
None
HLA INFO
A*29:02
TCR INFO
TRBVBV7-9
CDR3BASSHQAGALYNEQFF
Full length protein sequence (273 aa)
MMDVS
1
GVGFP
6
SKVPW
11
KKMSA
16
EELEN
21
QYCPS
26
RWVVR
31
LGAEE
36
ALRTY
41
SQIGI
46
EALPF
51
FLFFH
56
GGYWQ
61
SGSKD
66
ESAFM
71
VHPLT
76
AQGVA
81
VVIVA
86
YGIAP
91
KGTLD
96
HMVDQ
101
VTRSV
106
AFVQK
111
RYPSN
116
KGIYL
121
CGHSA
126
GAHLA
131
AMMLL
136
ADWTK
141
HGVTP
146
NLRGF
151
FLVSG
156
VFDLE
161
PIVYT
166
SQNVA
171
LQLTL
176
EDAQR
181
NSPQL
186
KVAQA
191
QPVDP
196
TCRVL
201
VVVGQ
206
FDSPE
211
FHRQS
216
WEFYQ
221
VLPVQ
226
TLCQG
231
EWKAS
236
FEELH
241
DVDHF
246
EIVEN
251
LTQKD
256
NVLTQ
261
IILKT
266
IFQ
271
Mutation Information
DNA mutation:
None
Peptide Range:
51 ~ 59
Mut AA position:
None (2 in Wild Type peptide)
Alignment
Wild Type:
"EALPFFLFF
|.|||||||
Mutant:
EVLPFFLFF"
Cancer Immunol Res, 2016
Durable Complete Response from Metastatic Melanoma after Transfer of Autologous T Cells Recognizing 10 Mutated Tumor AntigensGene Name (from Reference) AFMID
Checkpoint
Blockade
None
ACT
Y
Vaccination
N
Curative
Effect
durable regression
minimal_peptide
Y
Antigen
Type
TMG RNA
T-cell
Source
PBMCs
APC
Type
B cells
Assay
None